Article
An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.
The Journal of clinical investigation - 1 Apr 2014
Bonsignori Mattia, Wiehe Kevin, Grimm Sebastian K, Lynch Rebecca, Yang Guang, Kozink Daniel M, Perrin Florence, Cooper Abby J, Hwang Kwan-Ki, Chen Xi, Liu Mengfei, McKee Krisha, Parks Robert J, Eudailey Joshua, Wang Minyue, Clowse Megan, Criscione-Schreiber Lisa G, Moody M Anthony, Ackerman Margaret E, Boyd Scott D, Gao Feng, Kelsoe Garnett, Verkoczy Laurent, Tomaras Georgia D, Liao Hua-Xin, Kepler Thomas B, Montefiori David C, Mascola John R, Haynes Barton F
Abstract excerpt
Broadly HIV-1-neutralizing antibodies (BnAbs) display one or more unusual traits, including a long heavy chain complementarity-determining region 3 (HCDR3), polyreactivity, and high levels of somatic mutations. These shared characteristics suggest that BnAb development might be limited by immune tolerance controls. It has been postulated that HIV-1-infected individuals with autoimmune disease and defective immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
